Strongbrigde Biopharma 200 Prozent Potential?

Ausgehend vom aktuell Kurs zum KZ von 21USD

www.finanzen.net/analyse/...y-Stifel_Nicolaus__Co__Inc__558835

Pipeline

www.strongbridgebio.com/pipeline/

3,96

+0,54

+15,93 %

www.finanzen.net/analyse/...rma_Buy-H_C_Wainwright__Co__600398

könnte diesen Monat noch geschlossen werden

2,68 USD +0,23 USD +9,18 %

www.nasdaq.com/de/symbol/sbbp/real-time

Kann aber keine News finden! Das Kursziel ist aber sportlich :)

www.finanznachrichten.de/...ien/strongbridge-biopharma-plc.htm

ist da was im Busch? Hört sich nicht viel an, aber sieht nach Umsatzrekord zumindest für dieses Jahr aus :)

www.nasdaq.com/de/symbol/sbbp/real-time

www.nasdaq.com/de/symbol/sbbp/real-time

www.finanzen.net/top50_ausland/

seekingalpha.com/article/...37th-annual-health-care-conference

aber es geht stetig aufwärts

4,10 USD +0,25 USD +6,49 %

www.nasdaq.com/de/symbol/sbbp/real-time

hereinflattern :)  

seekingalpha.com/article/...m-healthcare-conference-slideshow

www.conferencecalltranscripts.org/8/summary/?id=4497144

~ MACRILEN is the First and Only FDA-Approved Oral Drug Indicated For the Diagnosis of Adult Growth Hormone Deficiency, a Rare Endocrine Disorder ~

~ MACRILEN is Strongbridge’s Second Commercial Product; Expands the Company’s Rare Endocrine Disease Portfolio and Complements its Late-Stage Clinical Development Program for RECORLEV™ (levoketoconazole) in Endogenous Cushing’s Syndrome ~

~ Strongbridge Expands Structured Financing Facility with CRG to Support the Anticipated Commercial Launch of MACRILEN in Mid-2018 ~

Strongbridge Biopharma plc Announces Annual General Meeting of Shareholders
GlobeNewswire•February 23, 2018

finance.yahoo.com/news/...plc-announces-annual-123000559.html

Annual General Meeting (AGM) of Shareholders on Tuesday, May 15, 2018 at the offices of Arthur Cox, Ten Earlsfort Terrace, Dublin, Ireland. The record date for shareholders entitled to receive notice of and vote at the AGM is Wednesday, March 28, 2018.

www.analystratings.com/articles/...uy-rating-from-oppenheimer/

www.analystratings.com/articles/...om-oppenheimer/#more-544448

www.analystratings.com/articles/...strongbridge-biopharma-plc/